Therapeutic Outcomes Of Dry Needling Coupled With Intramuscular Stimulation In Patients With Fibromyalgia Syndrome
- Conditions
- Fibromyalgia Syndrome.FibromyalgiaM79.7
- Registration Number
- IRCT20240125060803N1
- Lead Sponsor
- The university of lahore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 78
Both male and female patients
Age over 18 years and under 60 years
Pre diagnosed patients with FMS referred through consultant
Manifesting chronic widespread musculoskeletal pain symptoms
Presence of active trigger points, as confirmed by physical examination
Willing and able to provide informed consent to participate in the study.
Ability to understand and comply with the study requirements
No contraindications to dry needling or IMS
Pregnancy or breastfeeding
Use of any medications that could interfere with the study results (e.g. muscle relaxants, opioids) within the past 48 hours.
Previous treatment with dry needling or IMS within the past 6 months
Presence of any other conditions that could interfere with the study results (e.g. cancer, infection)
Participation in any other clinical trials within the past 30 days
Anatomical anomaly Structural disorder of spinal alignment (Scoliosis, kyphosis, lordosis)oAny bone abnormality in neck region
Traumatic/ Inflammatory/ Infectious Conditions such as Recent Trauma, Nerve root compromise, Metabolic or serious spinal pathologies (e.g., fractures, tumors, inflammatory, and infectious diseases), Previous neck surgery
Psycho-social Instability such as Diagnosed stress/ depression/ Anxiety
Risk Profile such as High Risk
Inability to understand or comply with the study requirements, as determined by the physiotherapist
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method